Tag: healthcare
-
AbbVie (ABBV) increases dividend by 5.5%
Company Declares Dividend Increase of 5.5 Percent AbbVie is announcing today that its board of directors declared an increase in the company’s quarterly cash dividend from $1.64 per share to $1.73 per share beginning with the dividend payable on February 17, 2026 to shareholders of record as of January 16, 2026. This reflects an increase of approximately 5.5 percent, continuing AbbVie’s strong commitment to…
-
Johnson & Johnson announce plans to spin-off its orthopedics business
Johnson & Johnson (JNJ) announced plans to separate its orthopedics business, DePuy Synthes, within 18-24 months due to its lower growth and lower margins compared to other medical-device units like heart devices, surgical products, and vision care. The separation, potentially via a spinoff to shareholders, follows J&J’s strategy to focus on faster-growing, higher-margin businesses, as…
-
AbbVie (ABBV) increases dividend by 5.8% maintaining their dividend aristocrat status
AbbVie is announcing today that its board of directors declared an increase in the company’s quarterly cash dividend from $1.55 per share to $1.64 per share beginning with the dividend payable on February 14, 2025 to shareholders of record as of January 15, 2025. This reflects an increase of approximately 5.8 percent, continuing AbbVie’s strong…
-
Johnson & Johnson (JNJ) increases dividend by 4.2%, its 62nd consecutive annual increase
Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 4.2% increase in the quarterly dividend, from $1.19 per share to $1.24 per share, marking the 62nd year of consecutive increases. At the new rate, the indicated dividend on an annual basis is $4.96 per share compared to the previous rate…
-
Abbvie announces 4.7% dividend increase
AbbVie (NYSE:ABBV) announced financial results for the third quarter ended September 30, 2023. “We delivered another quarter of outstanding results driven by accelerating performance across our non-Humira growth platform, which is demonstrating double-digit growth,” said Richard A. Gonzalez, chairman and chief executive officer, AbbVie. “Based upon the strength and momentum of our business, we are once again…
-
J&J (JNJ) offers investors 7% discount on shares of spin-off Kenvue (KVUE)
Johnson & Johnson (JNJ) is offering its shareholders a chance to swap some of their shares for KVUE (KVUE), the consumer health business it spun off in May 2023. KVUE is a stable and predictable company with well-known brands and a higher dividend yield than J&J. The exchange is tax-free and gives investors a 7%…